Level Bio AB (publ) (NGM:LEVBIO)
Sweden · Delayed Price · Currency is SEK 0.3300
-0.0240 (-6.78%)
At close: Mar 19, 2026
Level Bio AB Revenue
In the year 2025, Level Bio AB had annual revenue of 32.36M SEK with 28.94% growth. Level Bio AB had revenue of 9.42M in the quarter ending December 31, 2025, with 26.48% growth.
Revenue
32.36M
Revenue Growth
+28.94%
P/S Ratio
0.70
Revenue / Employee
3.24M
Employees
10
Market Cap
22.57M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.36M | 7.26M | 28.94% |
| Dec 31, 2024 | 25.10M | -999.39K | -3.83% |
| Dec 31, 2023 | 26.10M | -8.24M | -23.99% |
| Dec 31, 2022 | 34.33M | -9.63M | -21.90% |
| Dec 31, 2021 | 43.96M | 20.43M | 86.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vaxxa AB | 77.62M |
| Sarsys AB | 42.36M |
| Adverty AB | 33.68M |
| Transiro Holding AB | 28.46M |
| edyoutec AB | 17.05M |
| LightAir AB | 14.43M |
| Trainimal AB | 13.25M |
| Kvix AB | 12.79M |